Transcriptional profiles predict treatment outcome in patients with tuberculosis and diabetes at diagnosis and at two weeks after initiation of anti-tuberculosis treatment.
van Doorn CLR, Eckold C, Ronacher K, Ruslami R, van Veen S, Lee JS, Kumar V, Kerry-Barnard S, Malherbe ST, Kleynhans L, Stanley K, Hill PC, Joosten SA, van Crevel R, Wijmenga C, Critchley JA, Walzl G, Alisjahbana B, Haks MC, Dockrell HM, Ottenhoff THM, Vianello E, Cliff JM; TANDEM Consortium.
van Doorn CLR, et al. Among authors: van veen s, van crevel r.
EBioMedicine. 2022 Aug;82:104173. doi: 10.1016/j.ebiom.2022.104173. Epub 2022 Jul 15.
EBioMedicine. 2022.
PMID: 35841871
Free PMC article.